1 Introduction
The mammalian microbiota encompasses trillions of microorganisms, comprising viruses, micro organism, archaea, and eukaryotes, residing internally and externally within the physique. These microorganisms are distributed in numerous areas, together with the pores and skin, oral mucosa, vaginal mucosa, and conjunctiva, with the bulk inhabiting the gastrointestinal system. The intestine microbiota play apivotal function in meals digestion, provision of important vitamins to the host, safeguarding towards pathogenic invasions, and regulating the expansion and differentiation of intestine epithelial cells. The interplay between the host and the metabolites generated by the microbiota itself performs a task within the host’s physiologic and pathologic modifications (Sittipo et al., 2018). The intestine microbiome harbors roughly 1,000 occasions extra genes than the human genome (with over 220 million genes within the intestine microbiome in comparison with the 23,000 genes within the human genome) (Tierney et al., 2019). Elements equivalent to breastfeeding, strong meals consumption, and hormonal modifications considerably influence the institution and composition of intestine microbiota (Rea et al., 2018). The varied bacterial genera in particular areas (such because the abdomen, ileum, and colon) additionally affect the intestine immune system (Terrisse et al., 2021). A lot proof has permitted that the microbiota, or native microbiota communities, profoundly have an effect on the prevalence of cancers and the physique’s response to them (Hosonuma et al., 2023). Nonetheless, analysis on the connection between intestine microbiota and cancers, significantly BrCa, is proscribed.
Breast most cancers (BrCa) is a sort of most cancers that happens within the glandular epithelial tissue of the breast, and its incidence has been growing through the years and tends to have an effect on youthful people (Li et al., 2022). The precise causes of this phenomenon usually are not but totally understood. Researches has indicated that the age of menarche and menopause, lactation, modifications in hormone ranges, stress, and poor life-style have an effect on the danger of BrCa. Notably, these elements had been additionally related to alterations within the intestine microbiome, suggesting that the intestine microbiome performs a task within the development of BrCa (McKee et al., 2021). It’s reported that in contrast with regular individuals, the general abundance of intestine microbiota in BrCa sufferers is decrease, and their metabolites are considerably completely different (Teng et al., 2021). Totally different intestine microbiota and their metabolites have completely different results on BrCa by way of distinct metabolic pathways. For instance, the lipopolysaccharide biosynthesis pathway is activated in sufferers with malignant BrCa, whereas the spore manufacturing in benign sufferers is considerably elevated (Yang et al., 2021). In addition to, the microbiota can affect the event, metastasis, and administration of BrCa by way of numerous organic processes, together with estrogen metabolism regulation, DNA injury, and bacterial metabolite synthesis (Sampsell et al., 2020). Due to this fact, this overview goals to offer a story overview of the research associated to the intestine microbiota in BrCa, discussing the immunomodulatory function of the intestine microbiota in illness development and its potential functions within the remedy of BrCa.
2 Intestine microbiota profile in BrCa
When the complicated micro-ecosystem within the intestine is dysfunctional, the microbiota with decrease stability, range, and better pathogenicity will reshape, which might change the traditional physiological processes of the human physique and result in numerous pathological circumstances (El-Sayed et al., 2021). Outcomes from an evaluation of intestine microbiota within the TwinsUK cohort within the UK display an affiliation between the incidence of BrCa and “disruptive” or non-healthy microbiota profile, implying that intestine microbiota could function a diagnostic biomarker and remedy for BrCa (Jackson et al., 2018). Research have discovered that postmenopausal BrCa sufferers have an enrichment of 38 micro organism, together with Escherichia coli, Klebsiella sp_1_1_55, Prevotella amnii, Enterococcus gallinarum, Actinomyces sp. HPA0247, Shewanella putrefaciens, and Erwinia amylovora; nevertheless, Eubacterium_eligens, Escherichia_albertii, Campylobacter_concisus, unclassified_Enterobacteriaceae_bacterium_9_2_54FAA, Roseburia_inulinivorans, Brucella_melitensis and Lactobacillus_vaginalis had been much less plentiful (Zhu et al., 2018). In one other research by Goedert et al, the intestine microbiota profile of the identical subtype of BrCa sufferers (postmenopausal BrCa) is completely different from TwinsUK cohort, with a rise within the relative abundance of Clostridia, Ruminococcaceae, and Bacteroides, and a lower within the relative abundance of Actinobacteria and the Coriobacteriaceae household (Goedert et al., 2015). The outcomes of this research align with the findings from the TwinsUK cohort, which counsel that postmenopausal BrCa sufferers exhibit altered microbiota profiles, though the precise reported species could differ. Moreover, Guan et al. performed a microbiota evaluation on HER2-positive metastatic BrCa sufferers receiving scheduled capecitabine remedy and commonplace chemotherapy, revealing vital variations within the intestine microbiota profiles between the 2 teams. In metastatic BrCa sufferers receiving capecitabine remedy, Blautia obeum, and Slackia confirmed a big predictive correlation (Guan et al., 2020). Wu et al. assessed the composition of those sufferers’ microbiota primarily based on tumor traits in BrCa sufferers. They famous that HER2-positive sufferers had decrease alpha range, and the degrees of Erysipelotrichaceae had been decrease, whereas ranges of Clostridium and Veillonella had been larger in sufferers with larger tumor grades. Each Veillonella and Erysipelotrichaeceae have been reported to be related to irritation (Kaakoush, 2015; Yu et al., 2017; Wu et al., 2020). A current research of the consequences of breast tumor implantation, progress, and elimination on fecal bacterial composition and intestine barrier perform in mice discovered that impaired colon barrier integrity was related to modifications in fecal bacterial profiles in mice with tumors. For instance, the relative abundance of lactobacillus was lowered and that of Bacteroides was larger in BrCa. As well as, the BrCa confirmed systemic irritation responses, together with splenomegalia, elevated bacterial load within the spleen, and elevated splenic and proencephalitic cytokines. 16S rRNA gene amplification of a number of micro organism cultured from the spleen and the matched fecal samples, suggesting that they originated within the intestine. These outcomes point out that intestine microbiota profiles had been modified and intestine barrier perform was decreased in breast tumors, which additional means that intestine microbiota are carefully associated to the prevalence and growth of BrCa (Loman et al., 2022).
3 The mechanisms of how intestine microbiota regulate BrCa growth
The intestine microbiota maintains a symbiotic relationship with the host. A traditional symbiotic relationship is useful to sustaining human well being, however food plan, antibiotic administration, and pathogen invasion will result in modifications within the composition of the person microbiota, ensuing within the destruction of the host immune system (Wu and Dai, 2017). Numerous chemokines and cytokines secreted by most cancers cells induce immune cells equivalent to regulatory T cells (Tregs), TAMs, and MDSCs to colonize the tumor (Determine 1) (Donald and Finlay, 2023). There may be rising proof that some particular microbiota within the intestine microbiota can play a task in decreasing systemic irritation and shaping innate and adaptive immunity. The range and composition of intestine microbiota could affect the prevalence, remedy and prognosis of BrCa sufferers by modulating the immune response (Lee et al., 2013; Denton et al., 2018). The consequences of intestine microbiota on the immune system of BrCa sufferers are primarily manifested in inducing the proliferation and differentiation of regulatory T cells, inducing the expression of secretory immunoglobulin (IgA), and selling the manufacturing of neutrophils.
Determine 1 The composition of TME. A number of chemokines and cytokines which are secreted by cancerous cells induce immune cells such Tregs, TAMs, and MDSCs to colonize the tumor. This determine reveals the regional manufacturing of immunosuppressive cytokines, chemokines, and progress elements in addition to their interplay with TME parts.
3.1 Induce proliferation and differentiation of regulatory T cells
Transcriptomic and clinicopathological data of a complete of 6050 sufferers in three massive open main BrCa cohorts (GSE96058, METABRIC, TCGA) and 16S rRNA gene sequence microbiome knowledge of BrCa tissues in TCGA additionally discovered the activation of most cancers immunity and infiltration of anticancer immune cells in low bile acid metabolism group enriched with Lactobacillus, Ruegeria, and Marichromatium (Wu et al., 2022). It’s proposed that BrCa metabolism-related microorganisms are associated to rejection and immunotherapy response of Tregs and activated NK cells (Chen et al., 2023). The imbalance between elevated Th17 cells and decreased Tregs results in native and systemic inflammatory responses (Ma et al., 2020). Some helpful human intestine microbes, equivalent to bifidobacterium and lactic acid micro organism, can promote the differentiation and performance of Tregs by growing the manufacturing of SCFAs, thereby inhibiting persistent irritation and autoimmune responses (Markowiak-Kopeć and Śliżewska, 2020). Conversely, some dangerous human intestine microbes, equivalent to Escherichia coli, Serrella, can enhance persistent irritation and autoimmune responses by producing endotoxins or inducing Th17 cell differentiation and performance (Zhang et al., 2023). In accordance with a current research, Pseudomonas aeruginosa produces the metabolite adenosine, adopted by tumor-infiltrating IFN-γ+ CD4+ and IFN-γ + CD8+ T cells, enhancing immune remedy response, and enhancing the efficacy of checkpoint blockade immunotherapy (Mager et al., 2020). At present, numerous cancers present an in depth hyperlink with some micro organism, together with Faecalibacterium, Lachnospiraceae, Bacteroides fragilis, Akkermansia muciniphila, Bifidobacterium, Lactobacillus, and Collinsella. Moreover, the associated metabolite TMAO induces TNBC cells to endure pyroptosis by activating endoplasmic reticulum stress kinase PERK, enhancing the in vivo anti-tumor immune capability of CD8+ T cells (Li et al., 2021).
3.2 Induced secretory immunoglobulin (IgA) expression
Secretory IgA (sIgA) antibodies secreted by the intestine type the primary line of antigen-specific immune protection, stopping pathogens and symbiotic microorganisms from getting into the physique (Pietrzak et al., 2020). It has been reported that some micro organism within the intestine microbiota can inhibit the event of tumors by activating the manufacturing of IgA, suggesting that the intestine microbiota can take part within the growth of tumors by way of IgA (Ding et al., 2021). Maternal sIgA in breast milk is thought to guard newborns till the creating intestine immune system begins to provide its personal sIgA. The aforementioned breastfeeding can also be related to the prevalence and growth of BrCa, suggesting that IgA could also be a pathway that intestine microbiota results in BrCa (Sudeep et al., 2022). Some researchers have proposed that the imbalance of intestine microbiota typically results in the destruction of the host immune system, and IgA protein is a possible hyperlink between BrCa-related irritation and intestine microbiota (Kaetzel, 2014). A case-control research in 2018 discovered that the microbiota abundance and α-diversity in IgA+ sufferers had been considerably decrease in comparison with IgA- sufferers. This implies that the intestine microbiota could affect the prevalence and growth of BrCa by altering the immune pathways (Goedert et al., 2018). Nonetheless, there’s at the moment restricted analysis on the precise mechanisms by which IgA within the intestine microbiota results in the event of BrCa, necessitating additional exploration and probably offering new therapeutic targets.
3.3 Promotion of neutrophil manufacturing
It’s reported that neutrophils are crucial for intestine micro organism to advertise most cancers in distant areas such because the mammary gland in mice, as soon as once more demonstrating the function of immune cells in tumor growth (Hajjar et al., 2023). Neutrophils and lymphocytes are additionally concerned within the regulation of BrCa immune response, and research have discovered that prime NLR (neutrophil-to-lymphocyte ratio) is related to poor OS and DFS in BrCa sufferers (Ethier et al., 2017). Notably, each neutrophils and lymphocytes are regulated by the intestine microbiome. In finding out how the gastrointensital microbiome regulates most cancers growth in distant parenteral tissue, researchers contaminated mice with focused pathogenic intestine microbes with BrCa susceptibility, and the illness progressed considerably quicker in mice with intensive neutrophilic infiltration than in mice with neutropenia. Additional consumption of mouse neutrophils with the anti-LY-6GG antibody system can forestall tumor development, suggesting that neutrophil-mediated immune response could have an effect on BrCa development (Lakritz et al., 2015).
4 Function of human intestine microbiota in BrCa remedy
With the deepening of analysis on the connection between intestine microbes and BrCa, therapeutic strategies primarily based on the mechanism of motion have emerged, equivalent to drug metabolism, immune regulation, and the appliance of probiotics.
4.1 Modulation of drug metabolisms
The interplay between intestine microbiota and drug efficacy is bidirectional. On one hand, medication can alter the intestine microenvironment, affecting the expansion, composition, and performance of micro organism. However, intestine microbiota can modify drug construction by way of enzymatic processes, thereby altering their bioavailability, organic exercise, or toxicity, leading to particular person variations in response to particular medication (Weersma et al., 2020). It has additionally been noticed that the presence of micro organism from the phylum Bacteroidetes or Bifidobacterium can lower the prevalence of colitis after remedy with ipilimumab. Probiotic dietary supplements containing Bifidobacteria can also alleviate mucositis induced by chemotherapy and diarrhea brought on by radiation remedy (Badgeley et al., 2021). In a research by Di et al., the influence of intestine microbiota on immune-mediated antitumor results of trastuzumab was investigated. The research revealed that the antitumor exercise of trastuzumab in mice was compromised on account of antibiotic administration or fecal microbiota transplantation from antibiotic-treated donors, underscoring the direct relationship between intestine microbiota and the efficacy of trastuzumab (Di Modica et al., 2021). Mendez et al. performed an animal research and located that milk fermented by Lactobacillus casei CRL431 (PFM) lowered the unwanted effects of capecitabine remedy for BrCa and mitigated the toxicity of capecitabine on 4T1 cells by way of improved immune cell stimulation induced by-PFM (Méndez Utz et al., 2021). Analysis on the interplay between intestine microbiota and drug remedy in BrCa is comparatively scarce, emphasizing the necessity for additional investigations to understand how intestine microbiota interacts with anticancer medication. It will allow interventions to modulate intestine microbiota for optimum therapeutic outcomes.
4.2 Modulation of immune responses
Immune checkpoint inhibitors have emerged as efficient therapeutic choices for numerous kinds of most cancers, aiming to reinforce the physique’s immune capabilities to focus on and remove tumor cells (Zheng et al., 2023). Programmed cell loss of life 1 protein (PD-1), a particular cell membrane protein related to tumor growth, disrupts the ligand-receptor interplay of PD-1/PD-L1 and inhibits the activation of the PD-1/PD-L1 signaling pathway, thereby reversing T cell exhaustion and halting immune responses throughout the tumor microenvironment (Determine 2) (Han et al., 2020). Immunotherapies equivalent to anti-PD-1 inhibitors have turn out to be a viable remedy method for TNBC. Nonetheless, medical proof means that combining immune checkpoint inhibitors (ICIs) and NAC can enhance the prognosis of early-stage TNBC however could considerably enhance toxicity, thereby limiting the utility of this immunotherapeutic method for sufferers (Sternschuss et al., 2021).

Determine 2 Diagrammatic illustration of immune checkpoint blockade therapies. PD-1 and PD-L1 expressed on the floor of activated T cells are the primary methods to manage the exercise of T cells. Beneath regular physiological circumstances, the primary perform of PD-1/PD-L1 inhibitory co-stimulatory indicators is to forestall T cells from attacking regular cells by way of uncontrolled over-activation. Nonetheless, excessive ranges of PD-L1 are expressed on the floor of various kinds of tumor cells. These overexpressed PD-L1 induce T cell failure by way of the PD-1/PD-L1 signaling pathway, enabling tumor cells to flee T cell immune assault. PD-1/PD-L1 pathway blockers newly activate exhausted T cells in tumor immune microenvironment by blocking the PD-1/PD-L1 signaling axis, and promote the killing perform of tumor cells. Restore the physique’s anti-tumor immunity.
Preclinical murine fashions indicated that the intestine microbiota modulates tumor responses to checkpoint blockade immunotherapy (Zhou et al., 2021). Research on the oral and intestine microbiome of melanoma sufferers receiving anti-PD-1 immunotherapy have discovered that the range and relative abundance of the Lachnospiraceae household in responsive sufferers had been larger, whereas the germ-free mice missing intestine commensal micro organism exhibited defects in each innate and adaptive immune system (Gopalakrishnan et al., 2018). One other research discovered that mice deal with with symbiotic micro organism Bacteroides and Bifidobacteria, along with CTLA-4 and PD-1 inhibitors, suppressed tumor progress, suggesting a correlation between intestine microbiota and the effectiveness of ICIs (Elkrief et al., 2019). Intensive preliminary analysis signifies that particular microbiota compositions could contribute to the efficacy of immunotherapy. In accordance with Routy and colleagues’ research utilizing samples from sufferers present process PD-1 inhibitor remedy, fecal microbiota transplantation (FMT) from responders improved the anti-cancer results of PD-1 blockade. Sufferers with low ranges of Akkermansia muciniphila, a low-viscosity mucin-producing bacterium, exhibited poorer medical responses to ICIs, indicating that bacterial supplementation could improve immunotherapy outcomes (Routy et al., 2018). These researches counsel that intestine microbiota regulation could also be a brand new technique to enhance tumor immunotherapy. Additional analysis is required to elucidate how the microbiota influences BC sufferers’ reactions to ICIs.
4.3 Probiotic supplementation
Probiotics reside microorganisms that, when administered in ample portions, confer well being advantages to the host, possessing the capability to manage intestine microbiota and preserve ecological steadiness throughout the ecosystem. Generally used probiotics in merchandise belong to genera equivalent to Lactobacillus, Bifidobacterium, Streptococcus, Enterococcus, and Lactococcus (Zhang et al., 2021). Students have performed preliminary research on the potential efficacy of probiotic remedy for BrCa involving completely different genera. These research employed cytotoxicity assays and analyses of organic markers associated to proliferation and irritation. A research reported within the internationally famend journal Nature Medication demonstrates for the primary time that oral probiotic drug preparations can enhance intestinal microbiota homeostasis in most cancers sufferers and improve sufferers’ immunotherapy response (Dizman et al., 2022). One research performed by Imani Fooladi et al. discovered that in comparison with the management group, the survival time of BrCa mice was considerably prolonged within the group handled with Lactobacillus acidophilus (Imani Fooladi et al., 2015). Equally, extra animal analysis affirmed the anticancer exercise of orally administered Lactobacillus acidophilus in mice with breast tumors (Behzadi et al., 2021). Marschalek et al. performed a research involving postmenopausal BrCa sufferers receiving chemotherapy. They had been randomly assigned to an intervention group receiving 4 kinds of probiotic capsules or a management group receiving a placebo. This intervention was administered twice day by day for 2 weeks. The research found that oral probiotic formulations might probably enhance the vaginal microbiota of BrCa sufferers present process chemotherapy (Marschalek et al., 2017). This proof gives a optimistic path for using probiotics in treating BrCa.
5 Challenges and additional optimization methods in BrCa microbiota remedy analysis
Whereas analysis on the connection between the intestine microbiota and the event of BrCa has been ongoing over the previous decade, there stay many unanswered questions concerning the involvement mechanisms of particular bacterial strains in most cancers growth. These embrace the function of probiotics as adjunct remedy in conventional remedies, in addition to the interactions between bacterial strains and the host. Nonetheless, there are nice variations in food plan construction, residing surroundings and genetic background of sufferers, leading to sure particular person variations amongst residents in numerous areas. The pathogenesis of BrCa is complicated, and BrCa sufferers typically face severe impaired immune perform or neutropenia, which can have an effect on the choice and effectiveness of intestine microbiota remedy for BrCa. Due to this fact, extra analysis is required to find out the causality between BrCa and the microbiota. Moreover, a radical evaluation of the fashions used, their medical relevance, elements which will affect the microbiota (equivalent to antibiotics and food plan), and strategies for integrating microbiota and host parts is essential for in-depth analysis on this discipline. Within the discipline of most cancers and immune illnesses, tweaking the intestine microbiota to enhance efficacy is without doubt one of the sizzling analysis instructions, and customized microbiota remedy is prone to be a future remedy technique. The aforementioned findings might pave the way in which for distinctive prognostic biomarkers for BrCa sufferers and improved immunotherapeutic approaches, leveraging the human microbiota to maximise the effectiveness of immunotherapy whereas minimizing over-treatment and destructive impacts. Hopefully, increasingly sufferers depend on regulating their very own immune perform to BrCa, and there are higher remedy choices.
6 Dialogue
BrCa has turn out to be the most typical malignant tumor worldwide, with the second highest mortality fee amongst feminine malignancies, posing a severe menace to ladies’s well being and high quality of life. Present remedies for BrCa have sure limitations and face resistance. Whereas there’s nonetheless a lot to be understood concerning the relationship between intestine microbiota and BrCa, the dysregulation of intestine microbiota has been recognized as an important issue within the initiation, development, and metastasis of BrCa. The intestine microbiota can modulate the physique’s immune perform by influencing the proliferation and differentiation of regulatory T cells, the expression of sIgA, and the manufacturing of neutrophils, thereby impacting the onset and development of BrCa. Quite a few research have indicated that focused drug metabolism, altered immune regulation, and using probiotics could improve remedy outcomes for BrCa sufferers. Nonetheless, additional in-depth investigations involving bigger cohorts and completely different subtypes of BrCa are crucial to totally discover the potential utility of intestine microbiota as a promising intervention protocol for the medical administration of BrCa.
Creator contributions
KX: Conceptualization, Investigation, Methodology, Writing – unique draft. JL: Conceptualization, Investigation, Writing – unique draft. RH: Conceptualization, Funding acquisition, Mission administration, Supervision, Writing – overview & modifying.
Funding
The writer(s) declare monetary help was acquired for the analysis, authorship, and/or publication of this text. This work was supported by the Nationwide Pure Science Basis of China [NSFC 31800114].
Battle of curiosity
The authors declare that the analysis was performed within the absence of any industrial or monetary relationships that could possibly be construed as a possible battle of curiosity.
Writer’s be aware
All claims expressed on this article are solely these of the authors and don’t essentially characterize these of their affiliated organizations, or these of the writer, the editors and the reviewers. Any product which may be evaluated on this article, or declare which may be made by its producer, is just not assured or endorsed by the writer.
References
Badgeley, A., Anwar, H., Modi, Ok., Murphy, P., Lakshmikuttyamma, A. (2021). Impact of probiotics and intestine microbiota on anti-cancer medication: Mechanistic views. Biochim. Biophys. Acta Rev. Most cancers. 1875, 188494. doi: 10.1016/j.bbcan.2020.188494
PubMed Summary | CrossRef Full Textual content | Google Scholar
Behzadi, R., Hormati, A., Eivaziatashbeik, Ok., Ahmadpour, S., Khodadust, F., Zaboli, F., et al. (2021). Analysis of anti-tumor potential of lactobacillus acidophilus ATCC4356 tradition supernatants in MCF-7 breast most cancers. Anticancer Brokers Med. Chem. 21, 1861–1870. doi: 10.2174/1871520621666201207085239
PubMed Summary | CrossRef Full Textual content | Google Scholar
Chen, F., Yang, J., Guo, Y., Su, D., Sheng, Y., Wu, Y. (2023). Integrating bulk and single-cell RNA sequencing knowledge reveals the connection between intratumor microbiome signature and host metabolic heterogeneity in breast most cancers. Entrance. Immunol. 14, 1140995. doi: 10.3389/fimmu.2023.1140995
PubMed Summary | CrossRef Full Textual content | Google Scholar
Denton, A. E., Roberts, E. W., Fearon, D. T. (2018). Stromal cells within the tumor microenvironment. Adv. Exp. Med. Biol. 1060, 99–114.
Di Modica, M., Gargari, G., Regondi, V., Bonizzi, A., Arioli, S., Belmonte, B., et al. (2021). Intestine microbiota situation the therapeutic efficacy of trastuzumab in HER2-positive breast most cancers. Most cancers Res. 81, 2195–2206. doi: 10.1158/0008-5472.CAN-20-1659
PubMed Summary | CrossRef Full Textual content | Google Scholar
Ding, M., Yang, B., Ross, R. P., Stanton, C., Zhao, J., Zhang, H., et al. (2021). Crosstalk between sIgA-coated micro organism in toddler intestine and early-life well being. Traits Microbiol. 29, 725–735. doi: 10.1016/j.tim.2021.01.012
PubMed Summary | CrossRef Full Textual content | Google Scholar
Dizman, N., Meza, L., Bergerot, P., Alcantara, M., Dorff, T., Lyou, Y., et al. (2022). Nivolumab plus ipilimumab with or with out stay bacterial supplementation in metastatic renal cell carcinoma: a randomized section 1 trial. Nat. Med. 28, 704–712. doi: 10.1038/s41591-022-01694-6
PubMed Summary | CrossRef Full Textual content | Google Scholar
Donald, Ok., Finlay, B. B. (2023). Early-life interactions between the microbiota and immune system: influence on immune system growth and atopic illness. Nat. Rev. Immunol. 23, 735–748. doi: 10.1038/s41577-023-00874-w
PubMed Summary | CrossRef Full Textual content | Google Scholar
Elkrief, A., Derosa, L., Zitvogel, L., Kroemer, G., Routy, B. (2019). The intimate relationship between intestine microbiota and most cancers immunotherapy. Intestine. Microbes 10, 424–428. doi: 10.1080/19490976.2018.1527167
PubMed Summary | CrossRef Full Textual content | Google Scholar
Ethier, J. L., Desautels, D., Templeton, A., Shah, P. S., Amir, E. (2017). Prognostic function of neutrophil-to-lymphocyte ratio in breast most cancers: a scientific overview and meta-analysis. Breast Most cancers Res. 19, 2. doi: 10.1186/s13058-016-0794-1
PubMed Summary | CrossRef Full Textual content | Google Scholar
Goedert, J. J., Hua, X., Bielecka, A., Okayasu, I., Milne, G. L., Jones, G. S., et al. (2018). Postmenopausal breast most cancers and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota. Br. J. Most cancers. 118, 471–479. doi: 10.1038/bjc.2017.435
PubMed Summary | CrossRef Full Textual content | Google Scholar
Goedert, J. J., Jones, G., Hua, X., Xu, X., Yu, G., Flores, R., et al. (2015). Investigation of the affiliation between the fecal microbiota and breast most cancers in postmenopausal ladies: a population-based case-control pilot research. J. Natl. Most cancers Inst. 107. doi: 10.1093/jnci/djv147
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., et al. (2018). Intestine microbiome modulates response to anti-PD-1 immunotherapy in melanoma sufferers. Science 359, 97–103. doi: 10.1126/science.aan4236
PubMed Summary | CrossRef Full Textual content | Google Scholar
Guan, X., Ma, F., Solar, X., Li, C., Li, L., Liang, F., et al. (2020). Intestine microbiota profiling in sufferers with HER2-negative metastatic breast most cancers receiving metronomic chemotherapy of capecitabine in comparison with these underneath standard dosage. Entrance. Oncol. 10, 902. doi: 10.3389/fonc.2020.00902
PubMed Summary | CrossRef Full Textual content | Google Scholar
Hajjar, R., Gonzalez, E., Fragoso, G., Oliero, M., Alaoui, A. A., Calvé, A., et al. (2023). Intestine microbiota affect anastomotic therapeutic in colorectal most cancers surgical procedure by way of modulation of mucosal proinflammatory cytokines. Intestine 72, 1143–1154. doi: 10.1136/gutjnl-2022-328389
PubMed Summary | CrossRef Full Textual content | Google Scholar
Han, Y., Liu, D., Li, L. (2020). PD-1/PD-L1 pathway: present researches in most cancers. Am. J. Most cancers Res. 10, 727–742.
Hosonuma, M., Murayama, M., Yoshimura, Ok. (2023). [The gut microbiota metabolite A enhances the anti-tumor effects of anti-PD-1 antibody therapy through immune modulation]. Gan. To. Kagaku. Ryoho. 50, 960–964.
Imani Fooladi, A. A., Yazdi, M. H., Pourmand, M. R., Mirshafiey, A., Hassan, Z. M., Azizi, T., et al. (2015). Th1 cytokine manufacturing induced by lactobacillus acidophilus in BALB/c mice bearing transplanted breast tumor. Jundishapur. J. Microbiol. 8, e17354.
Jackson, M. A., Verdi, S., Maxan, M. E., Shin, C. M., Zierer, J., Bowyer, R. C. E., et al. (2018). Intestine microbiota associations with frequent illnesses and prescription medicines in a population-based cohort. Nat. Commun. 9, 2655. doi: 10.1038/s41467-018-05184-7
PubMed Summary | CrossRef Full Textual content | Google Scholar
Kaetzel, C. S. (2014). Cooperativity amongst secretory IgA, the polymeric immunoglobulin receptor, and the intestine microbiota promotes host-microbial mutualism. Immunol. Lett. 162, 10–21. doi: 10.1016/j.imlet.2014.05.008
PubMed Summary | CrossRef Full Textual content | Google Scholar
Lakritz, J. R., Poutahidis, T., Mirabal, S., Varian, B. J., Levkovich, T., Ibrahim, Y. M., et al. (2015). Intestine micro organism require neutrophils to advertise mammary tumorigenesis. Oncotarget 6, 9387–9396. doi: 10.18632/oncotarget.v6i11
PubMed Summary | CrossRef Full Textual content | Google Scholar
Lee, H. W., Choi, H. J., Ha, S. J., Lee, Ok. T., Kwon, Y. G. (2013). Recruitment of monocytes/macrophages in numerous tumor microenvironments. Biochim. Biophys. Acta 1835, 170–179. doi: 10.1016/j.bbcan.2012.12.007
PubMed Summary | CrossRef Full Textual content | Google Scholar
Li, M., Wang, X., Wang, Y., Bao, S., Chang, Q., Liu, L., et al. (2021). Methods for transforming the tumor microenvironment utilizing lively components of ginseng-A promising method for most cancers remedy. Entrance. Pharmacol. 12, 797634. doi: 10.3389/fphar.2021.797634
PubMed Summary | CrossRef Full Textual content | Google Scholar
Li, P., Niu, Y., Li, S., Zu, X., Xiao, M., Yin, L., et al. (2022). Identification of an AXL kinase inhibitor in triple-negative breast most cancers by structure-based digital screening and bioactivity take a look at. Chem. Biol. Drug Des. 99, 222–232. doi: 10.1111/cbdd.13977
PubMed Summary | CrossRef Full Textual content | Google Scholar
Loman, B. R., Russart, Ok. L. G., Grant, C. V., Lynch, A. J., Bailey, M. T., Pyter, L. M. (2022). Mammary tumors alter the fecal bacteriome and allow enteric bacterial translocation. BMC Most cancers. 22, 245. doi: 10.1186/s12885-022-09274-0
PubMed Summary | CrossRef Full Textual content | Google Scholar
Ma, J., Solar, L., Liu, Y., Ren, H., Shen, Y., Bi, F., et al. (2020). Alter between intestine micro organism and blood metabolites and the anti-tumor results of Faecalibacterium prausnitzii in breast most cancers. BMC Microbiol. 20, 82. doi: 10.1186/s12866-020-01739-1
PubMed Summary | CrossRef Full Textual content | Google Scholar
Mager, L. F., Burkhard, R., Pett, N., Cooke, N. C. A., Brown, Ok., Ramay, H., et al. (2020). Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369, 1481–1489. doi: 10.1126/science.abc3421
PubMed Summary | CrossRef Full Textual content | Google Scholar
Markowiak-Kopeć, P., Śliżewska, Ok. (2020). The impact of probiotics on the manufacturing of short-chain fatty acids by human intestinal microbiome. Vitamins 12. doi: 10.3390/nu12041107
PubMed Summary | CrossRef Full Textual content | Google Scholar
Marschalek, J., Farr, A., Marschalek, M. L., Domig, Ok. J., Kneifel, W., Singer, C. F., et al. (2017). Affect of orally administered probiotic lactobacillus strains on vaginal microbiota in ladies with breast most cancers throughout chemotherapy: A randomized placebo-controlled double-blinded pilot research. Breast Care (Basel). 12, 335–339. doi: 10.1159/000478994
PubMed Summary | CrossRef Full Textual content | Google Scholar
McKee, A. M., Kirkup, B. M., Madgwick, M., Fowler, W. J., Value, C. A., Dreger, S. A., et al. (2021). Antibiotic-induced disturbances of the intestine microbiota lead to accelerated breast tumor progress. iScience 24, 103012. doi: 10.1016/j.isci.2021.103012
PubMed Summary | CrossRef Full Textual content | Google Scholar
Méndez Utz, V. E., Pérez Visñuk, D., Perdigón, G., de Moreno de LeBlanc, A. (2021). Milk fermented by Lactobacillus casei CRL431 administered as an immune adjuvant in fashions of breast most cancers and metastasis underneath chemotherapy. Appl. Microbiol. Biotechnol. 105, 327–340. doi: 10.1007/s00253-020-11007-x
PubMed Summary | CrossRef Full Textual content | Google Scholar
Pietrzak, B., Tomela, Ok., Olejnik-Schmidt, A., Mackiewicz, A., Schmidt, M. (2020). Secretory igA in intestinal mucosal secretions as an adaptive barrier towards microbial cells. Int. J. Mol. Sci. 21. doi: 10.3390/ijms21239254
PubMed Summary | CrossRef Full Textual content | Google Scholar
Rea, D., Coppola, G., Palma, G., Barbieri, A., Luciano, A., Del Prete, P., et al. (2018). Microbiota results on most cancers: from dangers to therapies. Oncotarget 9, 17915–17927. doi: 10.18632/oncotarget.v9i25
PubMed Summary | CrossRef Full Textual content | Google Scholar
Routy, B., Gopalakrishnan, V., Daillère, R., Zitvogel, L., Wargo, J. A., Kroemer, G. (2018). The intestine microbiota influences anticancer immunosurveillance and common well being. Nat. Rev. Clin. Oncol. 15, 382–396. doi: 10.1038/s41571-018-0006-2
PubMed Summary | CrossRef Full Textual content | Google Scholar
Sampsell, Ok., Hao, D., Reimer, R. A. (2020). The intestine microbiota: A possible gateway to improved well being outcomes in breast most cancers remedy and survivorship. Int. J. Mol. Sci. 21. doi: 10.3390/ijms21239239
PubMed Summary | CrossRef Full Textual content | Google Scholar
Sittipo, P., Lobionda, S., Lee, Y. Ok., Maynard, C. L. (2018). Intestinal microbiota and the immune system in metabolic illnesses. J. Microbiol. 56, 154–162. doi: 10.1007/s12275-018-7548-y
PubMed Summary | CrossRef Full Textual content | Google Scholar
Sternschuss, M., Yerushalmi, R., Saleh, R. R., Amir, E., Goldvaser, H. (2021). Efficacy and security of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast most cancers: a scientific overview and meta-analysis. J. Most cancers Res. Clin. Oncol. 147, 3369–3379. doi: 10.1007/s00432-021-03591-w
PubMed Summary | CrossRef Full Textual content | Google Scholar
Sudeep, Ok. C., Kumar, J., Ray, S., Dutta, S., Aggarwal, R., Kumar, P. (2022). Oral utility of colostrum and mom’s personal milk in preterm infants-A randomized, managed trial. Indian J. Pediatr. 89, 579–586. doi: 10.1007/s12098-021-03982-4
PubMed Summary | CrossRef Full Textual content | Google Scholar
Teng, N. M. Y., Value, C. A., McKee, A. M., Corridor, L. J., Robinson, S. D. (2021). Exploring the influence of intestine microbiota and food plan on breast most cancers danger and development. Int. J. Most cancers. 149, 494–504. doi: 10.1002/ijc.33496
PubMed Summary | CrossRef Full Textual content | Google Scholar
Terrisse, S., Derosa, L., Iebba, V., Ghiringhelli, F., Vaz-Luis, I., Kroemer, G., et al. (2021). Intestinal microbiota influences medical consequence and unwanted effects of early breast most cancers remedy. Cell Demise Differ. 28, 2778–2796. doi: 10.1038/s41418-021-00784-1
PubMed Summary | CrossRef Full Textual content | Google Scholar
Tierney, B. T., Yang, Z., Luber, J. M., Beaudin, M., Wibowo, M. C., Baek, C., et al. (2019). The panorama of genetic content material within the intestine and oral human microbiome. Cell Host Microbe 26, 283–95.e8. doi: 10.1016/j.chom.2019.07.008
PubMed Summary | CrossRef Full Textual content | Google Scholar
Wu, A. H., Tseng, C., Vigen, C., Yu, Y., Cozen, W., Garcia, A. A., et al. (2020). Intestine microbiome associations with breast most cancers danger elements and tumor traits: a pilot research. Breast Most cancers Res. Deal with. 182, 451–463. doi: 10.1007/s10549-020-05702-6
PubMed Summary | CrossRef Full Textual content | Google Scholar
Wu, R., Yu, I., Tokumaru, Y., Asaoka, M., Oshi, M., Yan, L., et al. (2022). Elevated bile acid metabolism and microbiome are related to suppressed cell proliferation and higher survival in breast most cancers. Am. J. Most cancers Res. 12, 5271–5285.
Yang, P., Wang, Z., Peng, Q., Lian, W., Chen, D. (2021). Comparability of the intestine microbiota in sufferers with benign and Malignant breast tumors: A pilot research. Evol. Bioinform. On-line. 17, 11769343211057573. doi: 10.1177/11769343211057573
PubMed Summary | CrossRef Full Textual content | Google Scholar
Yu, T., Guo, F., Yu, Y., Solar, T., Ma, D., Han, J., et al. (2017). Fusobacterium nucleatum promotes chemoresistance to colorectal most cancers by modulating autophagy. Cell 170, 548–63.e16. doi: 10.1016/j.cell.2017.07.008
PubMed Summary | CrossRef Full Textual content | Google Scholar
Zhang, M., Wang, L., Zhou, C., Wang, J., Cheng, J., Fan, Y. (2023). E. coli LPS/TLR4/NF-κB signaling pathway regulates th17/treg steadiness mediating inflammatory responses in oral lichen planus. Irritation 46, 1077–1090. doi: 10.1007/s10753-023-01793-7
PubMed Summary | CrossRef Full Textual content | Google Scholar
Zhang, X., Han, Y., Huang, W., Jin, M., Gao, Z. (2021). The affect of the intestine microbiota on the bioavailability of oral medication. Acta Pharm. Sin. B. 11, 1789–1812. doi: 10.1016/j.apsb.2020.09.013
PubMed Summary | CrossRef Full Textual content | Google Scholar
Zheng, F., Meng, Q., Zhang, L., Chen, J., Zhao, L., Zhou, Z., et al. (2023). Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in sufferers with superior tumors: a retrospective cohort research. World J. Surg. Oncol. 21, 198. doi: 10.1186/s12957-023-03077-8
PubMed Summary | CrossRef Full Textual content | Google Scholar
Zhu, J., Liao, M., Yao, Z., Liang, W., Li, Q., Liu, J., et al. (2018). Breast most cancers in postmenopausal ladies is related to an altered intestine metagenome. Microbiome 6, 136. doi: 10.1186/s40168-018-0515-3
PubMed Summary | CrossRef Full Textual content | Google Scholar

